Arovella Therapeutics Quote - ALA

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

0.17

Bid

0.17

Ask

0.18

Volume

811,998

0.1675 Day's Range 0.175

0.105 52 Week Range 0.21

Market Cap

178.527M

Previous Close

0.175

Open

0.17

Last Trade

1958

0.175

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

1,508,563

Shares Outstanding

1,050,156,236

Dividend Yield

PE Ratio

-20.48

Earnings Per Share (EPS)

-0.01

Revenue

1.95M

Net Profit

-8.75M

Sector

Surgical,med Instr,apparatus

Industry

Surgical,med Instr,apparatus

Website

www.sudapharma.com

Headquarters

Melbourne, Victoria, Aus

Founded

Arovella Therapeutics Ltd is listed in the Surgical,med Instr,apparatus sector of the Australian Stock Exchange with ticker ALA. The last closing price for Arovella Therapeutics was AUD0.18. Over the last year, Arovella Therapeutics shares have traded in a share price range of AUD 0.105 to AUD 0.21.

Arovella Therapeutics currently has 1,050,156,236 shares outstanding. The market capitalization of Arovella Therapeutics is AUD183.78 million. Arovella Therapeutics has a price to earnings ratio (PE ratio) of -20.48.

Alcatel-Lucent Introduces New IP Routers to Extend Advanced Mobile, Business and Residential Services to Smaller Markets

New smaller scale platforms allow service providers to extend advantages of Service Routing to furthest reaches of IP network edge at a more economical price point PARIS, Oct. 28 /PRNewswire/...

Amsterdam Public Library Selects Converged IP Solution From Alcatel-Lucent for State of the Art Voice and Data Network

PARIS, July 3 /PRNewswire-FirstCall/ -- The Amsterdam Public Library has selected Alcatel-Lucent's IP (Euronext Paris and NYSE:ALU) technology as the foundation of a comprehensive communications...

China Unicom Selects Alcatel-Lucent IP Service Routers for Nationwide Network Transformation

PARIS, July 3 /PRNewswire-FirstCall/ -- Alcatel-Lucent (Euronext Paris and NYSE: ALU) today announced that its industry-leading IP routing solution has been selected by China Unicom, a leading...

Alcatel-Lucent Announces Software Platform That Lets Mobile Operators Capitalize on the Increasing Demand for Mobile Content Sho

PARIS, June 13 /PRNewswire-FirstCall/ -- Alcatel-Lucent (Euronext Paris and NYSE: ALU) today announced the availability of the enhanced Alcatel-Lucent 5965 Mobile Content Platform, a powerful...

Vodafone and Alcatel-Lucent Cooperate to Deliver 32nd America's Cup Competition Live to Mobile Users in Spain

VALENCIA, Spain, June 1 /PRNewswire-FirstCall/ -- Vodafone and Alcatel-Lucent (Euronext Paris and NYSE: ALU) today announced a cooperation agreement to deliver the award-winning America's Cup...

Alcatel Alenia Space Signs a Euro 661 Million Contract With Globalstar to Build Their Second-Generation LEO Satellite Constellat

PARIS, December 4 /PRNewswire-FirstCall/ -- Alcatel Alenia Space today announced it has signed a Euro 661 million contract with Globalstar, Inc. (NASDAQ:GSAT), a leading provider of mobile...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.005	-2.85714285714	0.175	0.175	0.1675	152896	0.17	DE
4	-0.01	-5.55555555556	0.18	0.195	0.16	870703	0.17436018	DE
12	0.005	3.0303030303	0.165	0.21	0.16	1508563	0.1850996	DE
26	0.025	17.2413793103	0.145	0.21	0.13	1337111	0.17016816	DE
52	0.05	41.6666666667	0.12	0.21	0.105	1620495	0.150554	DE
156	0.131	335.897435897	0.039	0.21	0.02	1914419	0.08328906	DE
260	0.121	246.93877551	0.049	0.21	0.02	1858048	0.08194436	DE

ALA - Frequently Asked Questions (FAQ)

What is the current Arovella Therapeutics share price?

The current share price of Arovella Therapeutics is AUD 0.17

How many Arovella Therapeutics shares are in issue?

Arovella Therapeutics has 1,050,156,236 shares in issue

What is the market cap of Arovella Therapeutics?

The market capitalisation of Arovella Therapeutics is AUD 183.78M

What is the 1 year trading range for Arovella Therapeutics share price?

Arovella Therapeutics has traded in the range of AUD 0.105 to AUD 0.21 during the past year

What is the PE ratio of Arovella Therapeutics?

The price to earnings ratio of Arovella Therapeutics is -20.48

What is the cash to sales ratio of Arovella Therapeutics?

The cash to sales ratio of Arovella Therapeutics is 89.47

What is the reporting currency for Arovella Therapeutics?

Arovella Therapeutics reports financial results in AUD

What is the latest annual turnover for Arovella Therapeutics?

The latest annual turnover of Arovella Therapeutics is AUD 1.95M

What is the latest annual profit for Arovella Therapeutics?

The latest annual profit of Arovella Therapeutics is AUD -8.75M

What is the registered address of Arovella Therapeutics?

The registered address for Arovella Therapeutics is LEVEL 3, 62 LYGON STREET, CARLTON, MELBOURNE, VICTORIA, 3053

What is the Arovella Therapeutics website address?

The website address for Arovella Therapeutics is www.sudapharma.com

Which industry sector does Arovella Therapeutics operate in?

Arovella Therapeutics operates in the SURGICAL,MED INSTR,APPARATUS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
IBGIronbark Zinc Limited	AUD 0.255 (8,400.00%)	113.37k
KATOKatana Capital	AUD 0.003 (200.00%)	77.1k
TTMOTitan Minerals Limited	AUD 0.03 (87.50%)	12.33k
EELENRG Elements Ltd	AUD 0.0015 (50.00%)	10M
CCOOAThe Calmer Co International Ltd	AUD 0.0015 (50.00%)	2.21M
NRZONeuRizer Ltd	AUD 0.001 (-50.00%)	1.01M
EATEntertainment Rewards Ltd	AUD 0.002 (-50.00%)	968.35k
NACONAOS Ex50 Opportunities Company Limited	AUD 0.002 (-33.33%)	13.37k
PNTOAPanther Metals Ltd	AUD 0.002 (-33.33%)	47k
KNBOKoonenberry gold Ltd	AUD 0.005 (-28.57%)	1.63M
GCMGreen Critical Minerals Ltd	AUD 0.019 (5.56%)	117.1M
ROGRed Sky Energy Limited	AUD 0.009 (-14.29%)	74.61M
IMUImugene Limited	AUD 0.039 (4.00%)	46.15M
BRNBrainchip Holdings Ltd	AUD 0.415 (-4.05%)	35.04M
TMGTrigg Minerals Ltd	AUD 0.045 (4.65%)	28.2M